Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion

References

• LaouriMChenELoomanMGallagherMThe burden of disease of retinal vein occlusion: review of the literatureEye201125898198821546916
   PubMed Web of Science ®Google Scholar
• YauJWLeePWongTYBestJJenkinsARetinal vein occlusion: an approach to diagnosis, systemic risk factors and managementIntern Med J20083890491019120547
   PubMed Web of Science ®Google Scholar
• RogersSMcIntoshRLCheungNThe prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia and AustraliaOphthalmology201011731331920022117
   PubMed Web of Science ®Google Scholar
• MitchellPSmithWChangAPrevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye StudyArch Ophthalmol1996114124312478859084
   PubMed Web of Science ®Google Scholar
• KleinRKleinBEMossSEMeuerSMThe epidemiology of retinal vein occlusion: the Beaver Dam Eye StudyTrans Am Ophthalmol Soc20009813314311190017
   PubMedGoogle Scholar
• BraithwaiteTNanjiAALindsleyKGreenbergPBAnti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion [Review]The Cochrane Library2014518
   Google Scholar
• RogersSLMcIntoshRLLimLNatural history of branch retinal vein occlusion: an evidence-based systematic reviewOphthalmology20101171094110120430447
   PubMed Web of Science ®Google Scholar
• McIntoshRLRogersSLLimLNatural history of central retinal vein occlusion: an evidence-based systematic reviewOphthalmology20101171113112320430446
   PubMed Web of Science ®Google Scholar
• TurczyńskiBMichalska-MałeckaKSłowińskaLSzczęsnySRomaniukWCorrelations between the severity of retinopathy in diabetic patients and whole blood and plasma viscosityClin Hemorheol Microcirc200329212913714610308
   PubMed Web of Science ®Google Scholar
• RehakJRehakMBranch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalitiesCurr Eye Res20083311113118293182
   PubMed Web of Science ®Google Scholar
• TurczyńskiBMichalska-MałeckaKSłowińskaLSzczęsnySRomaniukWNon-proliferative diabetic retinopathy and red blood cells aggregationWiad Lek20045711–1263464015865241
   PubMedGoogle Scholar
• JefferiesPClemettRDayTAn anatomical study of retinal arteriovenous crossings and their role in the pathogenesis of retinal branch vein occlusionsAust NZ J Ophthalmol199321213217
   PubMedGoogle Scholar
• TropeGELoweGDMcArdleBMAbnormal blood viscosity and haemostasis in long-standing retinal vein occlusionBr J Ophthalmol1983671371426824618
   PubMed Web of Science ®Google Scholar
• JanssenMCden HeijerMCruysbergJRWollersheimHBredieSJRetinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factorsThromb Haemost2005931021102615968383
   PubMed Web of Science ®Google Scholar
• TurczyńskiBSzygułaJSłowińskaLMichalska-MałeckaKDrażewskiRWodnieckiJWhole blood and serum viscosity in cardiologic X syndromePol Arch Med Wewn20002847548111303313
   PubMedGoogle Scholar
• ŚpiewakDReguckaASłowińskaLKabieszAWitekKMichalska-MałeckaKChanges in the hemorheological parameters in age-related macular degenerationOkulistyka201443843
   Google Scholar
• CampochiaroPAHafizGShahMRanibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulatorMol Ther20081679179918362932
   PubMed Web of Science ®Google Scholar
• ChenKHWuCCRoySLeeSMLiuJHIncreased interleukin-6 in aqueous humor of neovascular glaucomaInvest Ophthalmol Vis Sci1999402627263210509659
   PubMed Web of Science ®Google Scholar
• FunkMKriechbaumKPragerFIntraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumabInvest Ophthalmol Vis Sci2009501025103219060280
   PubMed Web of Science ®Google Scholar
• KanedaSMiyazakiDSasakiSMultivariate analyses of inflammatory cytokines in eyes with branch retinal vein occlusion: relationships to bevacizumab treatmentInvest Ophthalmol Vis Sci2011522982298821273540
   PubMed Web of Science ®Google Scholar
• NomaHFunatsuHYamasakiMAqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusionEye (Lond)200822424816826241
   PubMed Web of Science ®Google Scholar
• NomaHMinamotoAFunatsuHIntravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusionGraefes Arch Clin Exp Ophthalmol200624430931516133018
   PubMed Web of Science ®Google Scholar
• FengJZhaoTZhangYMaYJiangYDifferences in aqueous concentrations of cytokines in macular edema secondary to branch and central retinal vein occlusionPLoS One201387e6814923861862
   PubMed Web of Science ®Google Scholar
• NomaHMimuraTTatsugawaMShimadaKAqueous flare and inflammatory factors in macular edema with central retinal vein occlusion: a case seriesBMC Ophthalmol2013111378
   Google Scholar
• WongTYScottIUClinical practice. Retinal-vein occlusionN Engl J Med20103632135214421105795
   PubMed Web of Science ®Google Scholar
• Branch Vein Occlusion Study GroupArgon laser photocoagulation for macular edema in branch vein occlusionAm J Ophthalmol1984982712826383055
   PubMed Web of Science ®Google Scholar
• Central Vein Occlusion Study Group M reportEvaluation of grid pattern photocoagulation for macular edema in central vein occlusionOphthalmology1995102142514339097788
   PubMed Web of Science ®Google Scholar
• BrownDMCampochiaroPABhisitkulRBSustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III studyOphthalmology20111181594160221684606
   PubMed Web of Science ®Google Scholar
• CampochiaroPABrownDMAwhCCSustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III studyOphthalmology2011182041204921715011
   PubMed Web of Science ®Google Scholar
• HallerJABandelloFBelfortRJrDexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study resultsOphthalmology20111182453246021764136
   PubMed Web of Science ®Google Scholar
• IpMSScottIUVanVeldhuisenPCA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 5Arch Ophthalmol20091271101111419752419
   PubMed Web of Science ®Google Scholar
• KuppermannBDBlumenkranzMSHallerJARandomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edemaArch Ophthalmol200712530931717353400
   PubMed Web of Science ®Google Scholar
• BrownDMCampochiaroPASinghRPCRUISE Investigators: ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III studyOphthalmology20101171124e11133e120381871
   PubMed Web of Science ®Google Scholar
• FigueroaMSContrerasINovalSArruabarrenaCResults of bevacizumab as the primary treatment for retinal vein occlusionBr J Ophthalmol2010941052105620679089
   PubMed Web of Science ®Google Scholar
• PacellaEPacellaFLa TorreGTesting the effectiveness of intravitreal ranibizumab during 12 months of follow-up in venous occlusion treatmentClin Ter20121636e413e42223306756
   PubMed Web of Science ®Google Scholar
• JonasJBKreissigIDegenringRFIntravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusionGraefes Arch Clin Exp Ophthalmol200224078278312271378
   PubMed Web of Science ®Google Scholar
• JainNStinnettSSJaffeGJProspective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month resultsOphthalmology201211913213721924503
   PubMed Web of Science ®Google Scholar
• KuppermannBDChouCWeinbergDVWhitcupSMHallerJABlumenkranzMSDDS Dexamethasone Phase II Study GroupIntravitreous dexamethasone effects on different patterns of diabetic macular edemaArch Ophthalmol2010128564264320212194
   PubMedGoogle Scholar
• BoyerDSFaberDGuptaSOzurdex CHAMPLAIN Study GroupDexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patientsRetina201131591592321487341
   PubMed Web of Science ®Google Scholar
• HallerJABandelloFBelfortRJrOzurdex GENEVA Study GroupRandomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusionOphthalmology20101171134114620417567
   PubMed Web of Science ®Google Scholar
• PacellaEVestriARMuscellaRPreliminary results of an intravitreal dexamethasone implant (Ozurdex) in patients with persistent diabetic macular edemaClin Ophthalmol201371423142823901252
   PubMedGoogle Scholar
• PacellaELa TorreGTurchettiPEvaluation of efficacy dexamethasone intravitreal implant compared to treatment with anti-VEGF in the treatment of diabetic macular edemaSenses Sci201414164168
   Google Scholar
• Chang-LinJEAttarMAcheampongAPharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implantInvest Ophthalmol Vis Sci2011521808620702826
   PubMed Web of Science ®Google Scholar
• MeyerLMSchönfeldCLFast resolution of recurrent pronounced macular edema following intravitreal injection of dexamethasone 0.7 mgCase Rep Ophthalmol20112224625021941500
   PubMedGoogle Scholar
• SingerMAAwhCCSaddaSHORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degenerationOphthalmol2012119611751183
   PubMed Web of Science ®Google Scholar
• MeyerLMSchönfeldCLSecondary glaucoma after intravitreal dexamethasone 0.7 mg implant in patients with retinal vein occlusion: a one-year follow-upJ Ocul Pharmacol Ther201329656056523480270
   PubMed Web of Science ®Google Scholar